Our initial focus is on addressing a long-standing problem: one third of patients require a second or third procedure following breast conserving surgery (BCS) to fully remove the cancer. This is both highly stressful for the patients and a huge financial burden on the healthcare system. Our biochemical imaging modality is designed to provide the surgeon rapid intra-operative information to ensure complete resection of the cancer the first time.